These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1111276)

  • 41. An improvemed assay for von Willebrand factor.
    Head DR; Bowman RP; Marmer DJ; Brossoit AD
    Am J Clin Pathol; 1979 Dec; 72(6):991-5. PubMed ID: 117698
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative effects of phenylbutazone, naproxen and flunixin meglumine on equine platelet aggregation and platelet factor 3 availability in vitro.
    Johnstone IB
    Can J Comp Med; 1983 Apr; 47(2):172-9. PubMed ID: 6883184
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Platelet factor 3 in membranes and granules of human platelets.
    Farská I; Pudlák P; Posedĕlová H
    Acta Univ Carol Med Monogr; 1972; 53():141-6. PubMed ID: 4670726
    [No Abstract]   [Full Text] [Related]  

  • 44. Immunoelectron microscopic localization of platelet factor 4 and fibrinogen in the granules of human platelets.
    Pham TD; Kaplan KL; Butler VP
    J Histochem Cytochem; 1983 Jul; 31(7):905-10. PubMed ID: 6343481
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Measurement of platelet factor 3 during central thrombocytopenia].
    Sultan Y; Scrobohaci ML; Jaillet N; Caen JP
    Nouv Rev Fr Hematol; 1973; 13(4):549-53. PubMed ID: 4271104
    [No Abstract]   [Full Text] [Related]  

  • 46. Release of nonsedimentable platelet factor 3 during coagulation.
    Horowitz HI; Papayoanou MF
    J Lab Clin Med; 1967 Jun; 69(6):1003-12. PubMed ID: 6025490
    [No Abstract]   [Full Text] [Related]  

  • 47. Fibrin-stabilizing factor: a thrombin-labile platelet protein.
    Kiesselbach TH; Wagner RH
    Am J Physiol; 1966 Dec; 211(6):1472-6. PubMed ID: 4959531
    [No Abstract]   [Full Text] [Related]  

  • 48. Bernard-Soulier syndrome: a new platelet glycoprotein abnormality. Its relationship with platelet adhesion to subendothelium and with the factor VIII von Willebrand protein.
    Caen JP; Nurden AT; Jeanneau C; Michel H; Tobelem G; Levy-Toledano S; Sultan Y; Valensi F; Bernard J
    J Lab Clin Med; 1976 Apr; 87(4):586-96. PubMed ID: 1083883
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Studies on plasma hypercoagulability. 1. Heparin resistance in various diseases and its relation to coagulation factors, anticoagulant therapy, platelet and heparin co-factor].
    Satake K
    Naika Hokan; 1969 Apr; 16(4):127-38. PubMed ID: 5816626
    [No Abstract]   [Full Text] [Related]  

  • 50. Absent plasma second phase platelet aggregation factor in a patient with Hageman trait.
    Okonkwo P; Post R; Sise H
    Thromb Diath Haemorrh; 1970 Jun; 23(3):423-31. PubMed ID: 5432187
    [No Abstract]   [Full Text] [Related]  

  • 51. Effects of bacterial endotoxin on rabbit platelets. II. Enhancement of platelet factor 3 activity in vitro and in vivo.
    HOROWITZ HI; DES PREZ RM; HOOK EW
    J Exp Med; 1962 Nov; 116(5):619-33. PubMed ID: 13954979
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Platelets fixed with paraformaldehyde: a new reagent for assay of von Willebrand factor and platelet aggregating factor.
    Allain JP; Cooper HA; Wagner RH; Brinkhous KM
    J Lab Clin Med; 1975 Feb; 85(2):318-28. PubMed ID: 234499
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time.
    Six KR; Devloo R; Van Aelst B; Vandekerckhove P; Feys HB; Compernolle V
    J Vis Exp; 2017 Feb; (120):. PubMed ID: 28287584
    [TBL] [Abstract][Full Text] [Related]  

  • 54. RECOVERY OF PLATELET PHOSPHORUS FROM SERUM AFTER RECALCIFICATION OF PLATELET-RICH PLASMA.
    ROSSI EC; CLATANOFF DV
    J Lab Clin Med; 1963 Nov; 62():736-42. PubMed ID: 14078009
    [No Abstract]   [Full Text] [Related]  

  • 55. Platelet heparin-neutralizing factor (platelet factor 4).
    Lüscher EF; Käser-Glanzman R
    Thromb Diath Haemorrh; 1975 Feb; 33(1):66-72. PubMed ID: 1091019
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Proceedings: The identification of two platelet specific release products.
    Moore S; Pepper DS
    Br J Haematol; 1974 Jun; 27(2):365-6. PubMed ID: 4135746
    [No Abstract]   [Full Text] [Related]  

  • 57. Evaluation of ristocetin-Willebrand factor assay and ristocetin-induced platelet aggregation.
    Olson JD; Brockway WJ; Fass DN; Magnuson MA; Bowie EJ
    Am J Clin Pathol; 1975 Feb; 63(2):210-8. PubMed ID: 1078748
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Normal values of hemoglobin, hematocrit, blood coagulation factors, and fibrinolysis in New Zealand white rabbits].
    Marval E; García L; Candela DE; Arocha-Piñango CL
    Sangre (Barc); 1992 Oct; 37(5):355-61. PubMed ID: 1293775
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A platelet procoagulant activity associated with platelet shape change.
    Ehrman M; Toth E; Frojmovic M
    J Lab Clin Med; 1978 Sep; 92(3):393-401. PubMed ID: 681825
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunological localisation of beta-thromboglobulin and platelet factor 4 in human megakaryocytes and platelets.
    McLaren KM; Pepper DS
    J Clin Pathol; 1982 Nov; 35(11):1227-31. PubMed ID: 6183294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.